Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Venous thromboembolism and mortality in breast cancer: cohort study with systematic review and meta-analysis

  • Umair T. Khan1, 2,
  • Alex J. Walker1, 3,
  • Sadaf Baig1,
  • Tim R. Card1,
  • Cliona C. Kirwan4 and
  • Matthew J. Grainge1Email author
BMC Cancer201717:747

https://doi.org/10.1186/s12885-017-3719-1

Received: 30 November 2016

Accepted: 30 October 2017

Published: 10 November 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
30 Nov 2016 Submitted Original manuscript
15 Feb 2017 Reviewed Reviewer Report - Florian Posch
6 Mar 2017 Reviewed Reviewer Report - Keith McCrae
3 Aug 2017 Author responded Author comments - Umair Khan
Resubmission - Version 2
3 Aug 2017 Submitted Manuscript version 2
4 Aug 2017 Reviewed Reviewer Report - Florian Posch
8 Aug 2017 Reviewed Reviewer Report - Keith McCrae
5 Sep 2017 Author responded Author comments - Umair Khan
Resubmission - Version 3
5 Sep 2017 Submitted Manuscript version 3
2 Oct 2017 Author responded Author comments - Umair Khan
Resubmission - Version 4
2 Oct 2017 Submitted Manuscript version 4
Publishing
30 Oct 2017 Editorially accepted
10 Nov 2017 Article published 10.1186/s12885-017-3719-1

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, Medical School
(2)
Institute of Translational Medicine, Molecular and Clinical Cancer Medicine, University of Liverpool
(3)
School of Life Sciences, University of Nottingham, Medical School, Queen’s Medical Centre
(4)
Institute of Cancer, University of Manchester, South Manchester University Hospitals NHS Trust, Wythenshawe Hospital

Advertisement